SCHEMBL7716722

SCHEMBL7716722

CN1CCN(c2nc(N3CCCC3)ncc2Oc2ccc(Cl)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 7/20 0.51
HTR3A P46098 2/20 0.49
EGLN1 Q9GZT9 4/20 0.46
MAPT P10636 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
KMT2A Q03164 1/20 0.44
USP2 O75604 2/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP1A2 P05177 2/20 0.43
GLA P06280 2/20 0.43
CYP3A4 P08684 2/20 0.43
CASP1 P29466 2/20 0.43
CASP7 P55210 2/20 0.43
HIF1A Q16665 2/20 0.43
HSD17B10 Q99714 2/20 0.43
HRH1 P35367 1/20 0.43
NPC1 O15118 1/20 0.41
GAA P10253 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708460 0.90 KMT2A (0.54) HRH4HTR3AMAPTTSHRMAPK1
SCHEMBL7714712 0.90 KMT2A (0.54) HRH4HTR3AMAPTTSHRMAPK1
SCHEMBL7716737 0.87 ALDH1A1 (0.48) HRH4HTR3AEGLN1MAPTTSHR
SCHEMBL7714381 0.85 MEN1 (0.49) EGLN1MAPTTSHRKMT2AUSP2
SCHEMBL7714152 0.85 HRH4 (0.55) HRH4HTR3ANPC1GAARAB9A
SCHEMBL7712468 0.85 MEN1 (0.51) EGLN1MAPTTSHRKMT2AUSP2
SCHEMBL7716584 0.83 MAPK1 (0.47) HRH4HTR3AMAPTTSHRMAPK1
SCHEMBL7708416 0.83 HRH4 (0.55) HRH4HTR6HRH3
SCHEMBL7714150 0.81 MEN1 (0.61) MAPTTSHRMAPK1KMT2AUSP2
SCHEMBL7714708 0.81 LMNA (0.46) HRH4MAPTTSHRKMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed